Evidence map›Paper›PMID 22907282›Full record

ReviewCurrent oncology reports2012

Screening and prevention measures for melanoma: is there a survival advantage?

Clara Curiel-Lewandrowski, Suephy C Chen, Susan M Swetter, Melanoma Prevention Working Group-Pigmented Skin Lesion Sub-Committee

Abstract readReview
In one paragraph

Review in Current oncology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Screening for reducing morbidity and mortality in malignant melanoma.The Cochrane database of systematic reviews · 2019
    Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Trends in Incidence and Mortality of Skin Melanoma in Lithuania 1991-2015.International journal of environmental research and public health · 2021
    Article
  12. Article
  13. Melanoma Prevention: Comparison of Different Screening Methods for the Selection of a High Risk Population.International journal of environmental research and public health · 2021
    Article
  14. Article
  15. Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result.Genetics in medicine : official journal of the American College of Medical Genetics · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Clara Curiel-LewandrowskiThe University of Arizona Cancer Center, 1515 N. Campbell Ave, Box 245024, Tucson, AZ, 85724, USA. ccuriel@azcc.arizona.edu
Suephy C Chen
Susan M Swetter
Melanoma Prevention Working Group-Pigmented Skin Lesion Sub-Committee

Funding

VITAMIN A, AND ITS PRECURSORS AND DERIVATIVES AS THERAPEUTIC MODALITIESP01CA027502 · NCI · UNIVERSITY OF ARIZONA · PI EINSPAHR, JANINE G · 1985 to 2015
$36.3M
NCI NIH HHS P01 CA027502
6 · The paper itself

Abstract

Controversy has emerged over the past decades regarding the value and impact of melanoma screening to detect early stage disease for improved prognosis. Those questioning the benefits of prevention efforts base their arguments on the absence of prospective, randomized studies demonstrating decreased melanoma mortality to justify the cost associated with screening and educational campaigns. For those in favor of melanoma screening, the lack of proven survival benefit is not a justification to abandon this approach, but rather a reflection of the lack of resources necessary to conduct a long-term trial. In 2009, the US Preventive Services Task Force (USPSTF)report did not recommend routine primary care screening for the general population given the absence of evidence. However, since the USPSTF report, a series of new studies are available, which support the potential benefit of screening and have the potential to significantly impact current policies regarding skin cancer screening, particularly for melanoma.

Indexed as

Early Detection of CancerHealth BehaviorHumansIncidenceMass ScreeningMelanomaPreventive Health ServicesUnited States

Identifiers

PMID22907282
PMCPMC3517928

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.